CHK-336

N/A

Report date: 2025/05/29 15:39:52
NME

Base Information

Drug NameCHK-336
Drug Alias NameCHK-336
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionL-lactate dehydrogenase A chain inhibitors
TargetsL-lactate dehydrogenase A chain
Therapy Area/IndicationsHyperoxaluria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChinook Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesChinook Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHyperoxaluria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A